Skip to main content
OpenTrials
Completed

NCT Number: NCT03392363

Diagnosing Respiratory Disease in Children Using Cough Sounds 2

The purpose of this prospective study is to evaluate the efficacy of the ResAppDx software application in the diagnosis of childhood acute respiratory disease, including pneumonia, bronchiolitis, asthma/reactive airways disease, croup, lower respiratory tract disease (LRTD), viral lower respiratory tract infection (vLRTI), and upper respiratory tract disease (URTD).

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Infant or child aged greater than 29 days up to and including their 12th birthday (infant and children pediatric subgroups as defined in Guidance for Industry and Food and Drug Administration Staff: Premarket Assessment of Pediatric Medical Devices dated March 24, 2014)
  • Presenting to the study site (an outpatient facility, an urgent care center, an Emergency Department, or inpatient ward within 24 hours of admission) with current signs or symptoms of respiratory disease including cough, wheezing, stridor, chest in-drawing/retractions, difficulty breathing, fast breathing, nasal congestion/rhinorrhea, abnormal lung sounds on exam or cyanosis/hypoxemia.
  • Onset of symptoms within past 14 days
  • Outpatient or inpatient within 24 hours of admission
  • Coughing spontaneously or able to cough voluntarily

Exclusion criteria

  • Lack of a signed consent form from parent or legal guardian
  • Lack of signed assent form for children aged 7 years or older who, in the opinion of the investigator, is able to provide assent based on their age, maturity or psychological state.
  • Need for mechanical ventilatory support ((including invasive, CPAP, or BiPAP)) or high flow nasal cannula
  • History of structural airways abnormalities, tracheobronchomalacia, or vocal cord abnormalities (e.g. laryngomalacia, tracheomalacia, or bronchomalacia)
  • Any medical contraindication to voluntary cough, including the following (only enroll if coughing spontaneously): severe respiratory distress, history of pneumothorax, eye/chest/abdominal surgery in past 3 months, hemoptysis in the past month
  • Too medically unstable to participate in study per treating clinician
  • Subject previously enrolled in SMARTCOUGH-C-2 study
  • Tracheostomy present or tube placed

Treatment and study plan

Recordings of Infants and Children's Cough Sounds

Device

Smartphone recordings of the cough sounds of infants and children presenting to a participating site with signs or symptoms of respiratory disease.

Primary outcomes

  1. Diagnosis of pneumonia

    Time frame: 6 months

    Positive percent agreement and negative percent agreement to diagnose and rule out pneumonia as compared with (1) World Health Organization (WHO) Primary Endpoint Pneumonia (PEP) plus clinical pneumonia, (2) WHO PEP or Other Infiltrate plus clinical pneumonia, (3) Clinical pneumonia alone

  2. Diagnosis of other childhood respiratory diseases

    Time frame: 6 months

    Positive percent agreement and negative percent agreement to diagnose and rule out: lower respiratory tract disease (i.e. respiratory condition occurring below the level of the larynx), viral lower respiratory tract infection, bronchiolitis, asthma/reactive airways disease, upper respiratory tract disease, and croup.

Sponsors and collaborators

Lead sponsor

ResApp Health Limited

Industry

Collaborators

  • Baim Institute for Clinical Research
  • Baylor College of Medicine
  • Massachusetts General Hospital
  • The Cleveland Clinic

Registry information

Official study title

Diagnosing Respiratory Disease in Children Using Smartphone Recordings of Cough Sounds 2

Acronym: SMARTCOUGH-C-2

Important dates

Study start
2018
Primary completion
2018
Study completion
2018
First posted
Jan 5, 2018
Registry last updated
Nov 8, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.